You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 47 results
 
  • Record 1 TO 47

  1. IGF OT IGF A STAGE BASED MOBILE INTERVENTION FOR SUBSTANCE USE DISORDERS IN PRIMARY CARE N DA POP SEPTEMBER FEBRUARY BASE AWARD

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NIDA

    Not Available

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health

  2. IGF OT IGF VALIDATION OF MOBILE TECHNOLOGIES FOR CLINICAL ASSESSMENT

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health

  3. IGF OT IGF FY IWIN NAVIGATING YOUR PATH TO WELL BEING SBIR PHASE II BASE AWARD PERIOD OF PERFORMANCE

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NIDA

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health

  4. AUTOMATED DROPLET MONITORING SYSTEM

    SBC: CREARE LLC            Topic: NIDA

    Modern drug discovery methods require the use of automated liquid handling and dispensing systems for screening large numbers of candidate compounds to identify new drug candidates The use of these high throughput methods has been made possible by the development of automated systems that can dispense extremely small volumes of reagent at high speed However many of the reagents used in testing ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health

  5. IGF OT IGF MULTIPLEXED BIOMARKER ASSAY FOR CLASSIFICATION OF PATIENTS WITH SYSTEMIC SCLEROSIS

    SBC: CELDARA MEDICAL, LLC            Topic: NIDA

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health

  6. Smart Sensing Dental Drill

    SBC: RYTEK MEDICAL INC            Topic: NIDCR

    DESCRIPTION provided by applicant Clinical Importance Almost million dental implants were placed worldwide in with million of these procedures taking place in the United States The worldwide market for these implants is expected to increase to $ $ billion in revenue by as dental implant manufactures target and train general dentists non surgically trained to perform th ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health

  7. Developing a Z-domain based latex agglutination assay for C. difficile toxins

    SBC: SAUREUS, INC.            Topic: NIAID

    DESCRIPTION provided by applicant The most common diarrhea in hospitals and nursing care facilities are attributed to toxins secreted by Clostridium difficile These toxins called Toin A TcdA and Toxin B TcdB are the primary markers for the diagnosis of C difficile associated diarrhea CDAD The gold standard for diagnosis of CDAD is isolation of the bacteria followed by cytotoxin detec ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health

  8. Preclinical Development of BILT, a Next-Generation Immunotoxin Therapy for CTCL

    SBC: CELDARA MEDICAL, LLC            Topic: 102

    DESCRIPTION provided by applicant The long term aim of this project is to advance BILT for clinical approval which will provide clinicians with a powerful addition to the armamentarium for treating CTCL and cancer immunotherapy through depleting CD Treg Ontak R denileukin diftitox was making great strides in the treatment of CTCL since its FDA approval in until its discontinuation ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health

  9. Multi-Source E-Beam kV X-Ray Tube for Image-Guided Radiotherapy

    SBC: Telesecurity Sciences, Inc.            Topic: 102

    DESCRIPTION provided by applicant This project will lead to the development of an optimized X ray tube with focal spots that can be placed immediately below and around the multi leaf collimator MLC of a radiotherapy system By steering a focused electron beam e beam on a series of cooled tungsten targets in sequence this system will provide a set of projection images that can be reco ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health

  10. Therapeutic Role of Inter-alpha Inhibitors in Wound Healing

    SBC: PROTHERA BIOLOGICS, INC.            Topic: NIAMS

    DESCRIPTION provided by applicant Wound healing is an intricately regulated process broadly characterized by phases of inflammation proliferation and remodeling Imbalances in any one of these phases can result in inadequate healing scar formation or in the development of chronic wounds such as diabetic ulcers Diabetic ulcers are responsible for the majority of lower extremity amputations ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government